• Apnimed closed an upsized IPO of 13,800,000 common shares at USD 16 per share.
• Deal size included 1,800,000 shares from the full exercise of the underwriters’ overallotment option.
• Common stock began trading July 31, 2026 on the Nasdaq Global Select Market under the ticker APMD.
• Gross proceeds totaled USD 220.8 million before underwriting discounts, commissions, and offering expenses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apnimed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031635PRIMZONEFULLFEED9802774) on August 03, 2026, and is solely responsible for the information contained therein.